Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s stock price fell 5.9% on Thursday . The company traded as low as $93.12 and last traded at $93.97. 3,630,451 shares changed hands during mid-day trading, a decline of 16% from the average session volume of 4,334,192 shares. The stock had previously closed at $99.86.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on ALAB. William Blair began coverage on Astera Labs in a research report on Thursday, May 22nd. They issued an "outperform" rating for the company. Stifel Nicolaus cut their price target on Astera Labs from $150.00 to $100.00 and set a "buy" rating for the company in a research note on Thursday, April 17th. Evercore ISI boosted their price target on Astera Labs from $87.00 to $104.00 and gave the company an "outperform" rating in a research note on Wednesday, May 21st. Barclays boosted their price target on Astera Labs from $70.00 to $75.00 and gave the company an "overweight" rating in a research note on Wednesday, May 7th. Finally, Needham & Company LLC cut their price target on Astera Labs from $140.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Astera Labs has a consensus rating of "Moderate Buy" and a consensus price target of $100.00.
Get Our Latest Stock Analysis on ALAB
Astera Labs Trading Down 1.2%
The stock has a 50 day moving average of $90.47 and a 200-day moving average of $87.75. The company has a market capitalization of $15.82 billion, a P/E ratio of 435.93, a P/E/G ratio of 4.50 and a beta of 1.18.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.28 by $0.05. The company had revenue of $159.44 million during the quarter, compared to the consensus estimate of $151.55 million. Astera Labs had a return on equity of 2.57% and a net margin of 8.44%. The firm's revenue was up 144.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.10 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.
Insiders Place Their Bets
In other Astera Labs news, CFO Michael Truett Tate sold 500,000 shares of the company's stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $90.23, for a total value of $45,115,000.00. Following the completion of the transaction, the chief financial officer directly owned 618,996 shares in the company, valued at $55,852,009.08. This represents a 44.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Sanjay Gajendra sold 165,000 shares of the company's stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $71.76, for a total value of $11,840,400.00. Following the completion of the transaction, the insider owned 755,000 shares of the company's stock, valued at $54,178,800. The trade was a 17.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,965,984 shares of company stock worth $178,631,873 in the last three months.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Whittier Trust Co. of Nevada Inc. bought a new position in Astera Labs in the 4th quarter worth approximately $25,000. Steward Partners Investment Advisory LLC raised its holdings in shares of Astera Labs by 99.0% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company's stock worth $26,000 after acquiring an additional 99 shares in the last quarter. Oliver Lagore Vanvalin Investment Group purchased a new stake in shares of Astera Labs during the 2nd quarter worth approximately $29,000. Murphy & Mullick Capital Management Corp purchased a new stake in shares of Astera Labs during the 4th quarter worth approximately $43,000. Finally, Sound Income Strategies LLC raised its holdings in shares of Astera Labs by 34.7% during the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after acquiring an additional 204 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.
About Astera Labs
(
Get Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Read More
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
